What is I3LUNG
I3LUNG is a European project funded under the framework of the Horizon Europe (HEurope) call “Ensuring access to innovative, sustainable and high-quality health care”. Our consortium gathers 16 partners with different expertise located worldwide, with the common goal of providing better assistance and individualize treatment for patients affected by metastatic lung cancer.
For Patients
In the video below the project explained by Anne-Marie Baird, President of Lung Cancer Europe (LuCE) (one of the partners of the I3LUNG).
“We are excited to start this project which is envisioned to both generate novel therapeutic guidelines for clinical practice in lung cancer and support the growth of digital diagnostic tools in the European industry. (I3LUNG Partners)„
Find out the most relevant news on the latest advancements in lung cancer!
News
April, 8 2025
From March 26 to 29, the European Lung Cancer Congress brought together international leaders in thoracic oncology, and we are […]
News
April, 7 2025
This WorldHealthDay, we join the World Health Organization in its initiative, “Healthy Beginnings, Hopeful futures“, which highlights the importance of […]
News
March, 27 2025
We’re excited to share that some of our #I3LUNG partners, Arsela Prelaj, Helena Linardou, Giovanni Scoazec and Vanja Mišković, have […]